Form 4: Abbott Labs Executive Sells Shares
Insider Transaction Report
Abbott Laboratories EVP and Group President Lisa D. Earnhardt reported the disposal of 8,577 common shares.
Summary
- Lisa D. Earnhardt, EVP and Group President of Abbott Laboratories (ABT), reported a transaction involving common shares without par value.
- On February 27, 2026, Earnhardt disposed of 8,577 shares at a price of $116.26 per share.
- Following this transaction, Earnhardt directly beneficially owns 90,407 common shares.
- The transaction code "F" typically indicates shares withheld by the issuer to cover tax obligations in connection with the vesting of restricted stock or the exercise of options.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The transaction code 'F' indicates a non-discretionary disposal of shares for tax withholding purposes, which is a routine administrative action and not indicative of a change in company fundamentals or executive sentiment.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider transactions, particularly disposals marked with transaction code "F," are often routine events related to tax withholding upon the vesting of equity awards. Such transactions are common across industries and do not typically signal a change in an executive's confidence in the company's long-term prospects or its operational performance.
Stakeholder Impact
- Minimal impact on shareholders, as this is a routine, non-discretionary transaction for tax purposes and does not reflect a change in the company's operational or financial outlook.
Key Dates
| Date | Description |
|---|---|
| 02/27/2026 | Date of transaction where 8,577 common shares were disposed of. |
| 03/03/2026 | Date the Form 4 was signed by Lisa D. Earnhardt's attorney-in-fact. |
Recommendation
holdThis Form 4 filing reports a routine, non-discretionary disposal of shares by an executive for tax withholding purposes. Such transactions are common and do not typically provide new information that would warrant a change in investment recommendation based solely on this filing. The fundamental investment thesis for Abbott Laboratories remains unchanged by this administrative event.
Keywords
Abbott Laboratories, ABT, Insider Transaction, Form 4, Executive Stock Sale, Lisa D. Earnhardt, Common Shares, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.